Figure 1From: Promoter methylation of CDKN2A and lack of p16 expression characterize patients with hepatocellular carcinoma Results of Methylight analysis. Frequency of promoter methylation of CDKN2A gene is shown in patients with liver tumors detected by Methylight assay.Back to article page